Winton Group’s Akero Therapeutics AKRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-16,330	Closed	-$365K	–	1000
2021 Q3	$365K	Buy	16,330 +5,029	+45%	+$112K	0.02%	1017
2021 Q2	$280K	Buy	11,301 +4,022	+55%	+$99.7K	0.02%	1212
2021 Q1	$211K	Buy	+7,279	New	+$211K	0.01%	1263